Condition
Thromboembolic Stroke
Total Trials
6
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
Early P 1 (1)
P 1 (1)
P 3 (1)
Trial Status
Unknown3
Completed2
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT06961604Early Phase 1Not Yet RecruitingPrimary
A Novel Method for Determination of Thromboembolic Stroke Origin
NCT05079295Unknown
Management of Anticoagulants and Antithrombotics in Patients With CSDH
NCT05512546CompletedPrimary
The Prevention of Thromboembolic Complications Associated With Coil Embolization
NCT04987710Not ApplicableUnknown
Intracranial Rescue Stenting for Acute Ischemic Stroke, Predictors of Outcomes
NCT01327768Phase 1Unknown
Implantation of Olfactory Ensheathing Cells (OECs)
NCT00600327Phase 3Completed
Carotid Artery Revascularization Using the Boston Scientific EPI Filter Wire EZ™ and the EndoTex™ NexStent™
Showing all 6 trials